| RSC Drug Discovery/01. Smith D.A. - Metabolism, Pharmacokinetics and Toxicity of Functional Groups Impact of Chemical Building Blocks on ADMET (2010).pdf |
26.4 MB |
| RSC Drug Discovery/02. Martinez A. - Emerging Drugs and Targets for Alzheimer's Disease, V.1 Beta-Amyloid, Tau Protein and Glucose Metabolism (2010).pdf |
6.3 MB |
| RSC Drug Discovery/03. Martinez A. - Emerging Drugs and Targets for Alzheimer's Disease, V.2 Neuronal Plasticity, Neuronal Protection and other Miscellaneous Strategies (2010).pdf |
4.1 MB |
| RSC Drug Discovery/04. Barrish J.C., Carter P.H., Cheng P.T.W., Zahler R. - Accounts in Drug Discovery Case Studies in Medicinal Chemistry (2011).pdf |
10.1 MB |
| RSC Drug Discovery/05. Bunnage M.E. - New Frontiers in Chemical Biology Enabling Drug Discovery (2011).pdf |
142.3 MB |
| RSC Drug Discovery/06. Avila J., Lucas J.J., Hernandez F. - Animal Models for Neurodegenerative Disease (2011).pdf |
2.4 MB |
| RSC Drug Discovery/07. Milardi D., Rizzarelli E. - Neurodegeneration Metallostasis and Proteostasis (2011).pdf |
4.1 MB |
| RSC Drug Discovery/08. Giraldo J., Pin J.-P. - G Protein-Coupled Receptors From Structure to Function (2011).pdf |
16.6 MB |
| RSC Drug Discovery/09. Blacker A.J, Williams M.T. - Pharmaceutical Process Development Current Chemical and Engineering Challenges (2011).pdf |
9.3 MB |
| RSC Drug Discovery/10. Adams J.D.Jr., Parker K.K. - Extracellular and Intracellular Signaling (2011).pdf |
12.8 MB |
| RSC Drug Discovery/11. Farrant E. - New Synthetic Technologies in Medicinal Chemistry (2012).pdf |
3.4 MB |
| RSC Drug Discovery/12. Wilson A.G.E. - New Horizons in Predictive Toxicology Current Status and Application (2012).pdf |
152.1 MB |
| RSC Drug Discovery/13. Livingstone D.J., Davis A.M. - Drug Design Strategies Quantitative Approaches (2012).pdf |
6 MB |
| RSC Drug Discovery/14. Palmer M.J., Wells T.N.C. - Neglected Diseases and Drug Discovery (2012).pdf |
7.7 MB |
| RSC Drug Discovery/15. Braddock M. - Biomedical Imaging The Chemistry of Labels, Probes, and Contrast Agents (2012).pdf |
24.2 MB |
| RSC Drug Discovery/16. Wouters J., Quere L. - Pharmaceutical Salts and Co-crystals (2012).pdf |
9.8 MB |
| RSC Drug Discovery/17. Woster P.M., Casero R.A.Jr. - Polyamine Drug Discovery (2012).pdf |
7.9 MB |
| RSC Drug Discovery/18. Dunn B.M. - Proteinases as Drug Targets (2012).pdf |
163.5 MB |
| RSC Drug Discovery/19. Ward R.A., Goldberg F.W. - Kinase Drug Discovery (2012).pdf |
7.7 MB |
| RSC Drug Discovery/20. Clark T., Banting L. - Drug Design Strategies Computational Techniques and Applications (2012).pdf |
135 MB |
| RSC Drug Discovery/21. Morphy J.R., Harris C.J. - Designing Multi-Target Drugs (2012).pdf |
11 MB |
| RSC Drug Discovery/22. Alonso M.J., Csaba N.S. - Nanostructured Biomaterials for Overcoming Biological Barriers (2012).pdf |
172 MB |
| RSC Drug Discovery/23. Luque F.J., Barril X. - Physico-Chemical and Computational Approaches to Drug Discovery (2012).pdf |
89.4 MB |
| RSC Drug Discovery/24. Dambinova S.A., Hayes R.L., Wang K.K.W. - Biomarkers for Traumatic Brain Injury (2012).pdf |
4.4 MB |
| RSC Drug Discovery/25. Genilloud O., Vicente F. - Drug Discovery from Natural Products (2012).pdf |
85.3 MB |
| RSC Drug Discovery/27. Jones R.M. - New Therapeutic Strategies for Type 2 Diabetes Small Molecule Approaches (2012).pdf |
41.3 MB |
| RSC Drug Discovery/28. Rankovic Z., Bingham M., Nestler E.J., Hargreaves R. - Drug Discovery for Psychiatric Disorders (2012).pdf |
10.1 MB |
| RSC Drug Discovery/29. Li M. - Organic Chemistry of Drug Degradation (2012).pdf |
22.3 MB |
| RSC Drug Discovery/30. Cozzini P., Kellogg G.E. - Computational Approaches to Nuclear Receptors (2012).pdf |
3.8 MB |
| RSC Drug Discovery/33. Horvatovich P., Bischoff R. - Comprehensive Biomarker Discovery and Validation for Clinical Application (2013).pdf |
9.7 MB |
| RSC Drug Discovery/34. Martinez A., Gil C. - Emerging Drugs and Targets for Parkinson's Disease (2013).pdf |
7.8 MB |
| RSC Drug Discovery/RSC Flyer.pdf |
950 KB |
Magnet link
